Holowesko Partners Ltd. Pfizer Inc Transaction History

Holowesko Partners Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $709,125 - $878,695	-15,500 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $867,720 - $1.29 Million	-21,000 Reduced 57.53%	15,500 $915,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $12.2 Million - $15.7 Million	-311,000 Reduced 89.5%	36,500 $1.57 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $161,594 - $183,060	4,500 Added 1.31%	347,500 $13.6 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $11.5 Million - $13 Million	343,000 New	343,000 $12.4 Million

3,220

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Holowesko Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Holowesko Partners Ltd. with notifications on news.